Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter
Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales declined 73.56% to Rs 2.44 crore in the quarter ended June 2024 as against Rs 9.23 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 2.44 | 9.23 | -74 |
OPM % | 14.75 | 6.50 | - |
PBDT | 0.27 | 0.49 | -45 |
PBT | 0.27 | 0.49 | -45 |
NP | 0.27 | 0.49 | -45 |

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025

10 Financial Planning Checklist For 2025
7 mins read . Aug 12, 2025

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •